Ted Pharmaceuticals' muscular pine drug benzodiaxane aquco ammonium injection has been officially approved for the market

On December 22, 2020, Beijing Ted Pharmaceutical Co., Ltd. independently developed the muscular pine drug benzodiazean aquco ammonium injection (commodity name: Detai'an) officially obtained the drug approval number issued by the State Drug Administration of the People's Republic of China (approval number: H20203696), and as through the evaluation of the quality and efficacy of generic drugs, the first pharmaceutical enterprises in the country through consistent evaluation, belong to the national medical insurance catalogue.
(Product Effect Map) Benzene Shun Acura ammonium is a medium-effect, non-depolarized skeletal muscle relaxant with a pyrethroid structure that can be used as an all-hemp-assisted medication or as a sedative in the intensive care unit (ICU).
Benzene shun aquco ammonium with rapid effect, no cardiovascular side effects, no accumulation effect, a wide range of applications, suitable for the elderly, children, heart and liver and kidney dysfuncation and other special patients, as well as ICU patients, etc. , become a more ideal muscle relaxant.
it is learned that in 2019, benzodiaxane Aquku ammonium accounted for more than 70% of the market share in the field of muscular pine medicine, the market size reached nearly 3 billion yuan, can be described as a leader in the muscular muffin market.
with the increasing number of domestic surgical patients and operating table, the market space for this variety in the field of surgical anesthesia may be further enhanced, the market potential is huge.
。